This paper explores the ethical and legal complexities of integrating genomic sequencing into newborn bloodspot screening. It examines the impact on children's health rights and existing consent practices, discussing public health ethics and the 'right of the asymptomatic at-risk child to be found.' The authors advocate for 'appropriate consent,' particularly for virtual panels, balancing universal screening with the complexities of genomic technology.
Publisher
European Journal of Human Genetics
Published On
May 01, 2024
Authors
Bartha Maria Knoppers, Ana Eliza Bonilha, Anne-Marie Laberge, Arzoo Ahmed, Ainsley J. Newson
Tags
genomic sequencing
newborn screening
ethical complexities
health rights
consent practices
public health ethics
asymptomatic at-risk children
Related Publications
Explore these studies to deepen your understanding of the subject.